Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”

<div>(a) The percentage of CIK cells including (CD3+ CD56+), (CD3+ CD56−), and (CD3− CD56+) before and after induction and CD4+ and CD8+ before and after induction in one of the patients. (b) The percentage of NK cells (CD3+ CD56−) before and after induction and the activated NK (CD56+ CD69+) before and after induction in one of the patients. (c) The percentage of γδT before and after induction in one of the patients.</div>

Journal of Immunology Research

fig1

Figure 2

Figure 2: Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” 

Figure 2 | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” 